1. Carson, D. & Raz, E. Oligonucleotide adjuvants for T helper 1 Th1 -specific vaccination. J. Exp. Med. 186, 1621–1622. (1997).
2. Krieg, A.M., Yi, A.K., Schorr, J. & Davis, H.L. The role of CpG dinucleotides in DNA vaccines. Trends Microbiol. 6, 23–27 (1998).
3. Shimada, S. et al. Antitumor activity of the deoxyribonucleic acid fraction of Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors. J. Natl. Cancer Inst. 74, 681–688 (1985).
4. Tokunaga, T. et al. Antitumor activity of the deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst. 72, 955–962 (1984).
5. Yamamoto, S. et al. Unique palindromic sequences in synthetic oligonucleotides are required to induce INF and augment INF-mediated natural killer activity. J. Immunol. 148, 4072–4076 (1992).